Enjoy complimentary customisation on priority with our Enterprise License!
The global flow diversion aneurysm treatment market size is estimated to grow by USD 2,107.08 million at a CAGR of 8.8% between 2022 and 2027.
Advancements in flow diverter technology have had a profound impact on the flow diversion aneurysm treatment market. Innovations such as coil embolization and vessel remodeling with balloons have expanded the applications of flow diversion, improved patient outcomes, and driven market growth. The treatment of a broad range of types of aneurysms was made possible by improved flow diversion designs, e.g. reduced profile devices, dual layer flow diverters, and braided/laser-cut devices. These advancements have expanded the pool of patients eligible for flow diversion, leading to increased demand for this mode of treatment.
Technavio has segmented the market into Product, End-user, and Geography
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021, besides analyzing the current market scenario.
To learn more about this report, Request Free Sample
FDS
The market share growth by the FDS segment will be significant during the forecast period. Flow-diverting stents, also known as flow diverters, are specialized medical devices used in the treatment of certain brain vascular conditions, specifically complex and wide-necked intracranial aneurysms. These stents are intended to redirect blood flow from the aneurysm, thereby helping create a blood clot in an aneurysm, ultimately leading to its healing and occlusion.
Get a glance at the market contribution of various segments View a PDF Sample
The FDS segment was valued at USD 2,702.87 million in 2017. Flow-diverting stents offer several benefits as a treatment option for certain complex and wide-necked intracranial aneurysms. They are not suited to all cases but may offer significant advantages in comparison with traditional treatment methods such as surgical clipping when appropriately selected and used. The applications of FDS will contribute to the growth of the FDS segment, which in turn will propel the market to focus during the forecast period.
Hospitals
Flow diversion has found significant application in hospitals as an effective and less invasive treatment option for certain intracranial aneurysms. Flow diversion is particularly useful for treating complex, wide-necked, and large aneurysms that are difficult to manage with traditional endovascular coiling or surgical clipping. These aneurysms are more likely to rupture and may be located in focal areas of the brain, which make them difficult to treat with other methods. In hospitals, patients are spending fewer hours and thus reducing healthcare costs and freeing up hospital resources for other patients. Thus, these applications of flow diversion aneurysm treatment will contribute to the growth of the hospital segment, which will propel the growth of the market in focus during the forecast period.
Specialty clinics
Flow diversion for treating intracranial aneurysms is primarily performed in specialized neuro-interventional or neurovascular clinics. These specialty clinics have the expertise, advanced equipment, and experienced medical professionals needed to perform flow diversion procedures effectively and safely. Neuro-interventionalists or interventional neuroradiologists with a high degree of expertise in performing endovascular brain and spinal procedures are available at specialized clinics that provide flow diversion therapy. Specialty clinics are equipped with state-of-the-art endovascular procedure suites where flow diversion and other endovascular treatments are performed. These suites have advanced fluoroscopy and imaging equipment necessary for guiding catheters and flow diverter deployment.
For more insights about the market share of various regions View PDF Sample now!
North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period.
North America accounts for a significant share of the global flow diversion aneurysm treatment market. The majority of market shares in this region are held by the United States and Canada. The rapid growth of the market in this region is attributed to high awareness about impacts and treatment procedures for aneurysms, the increasing number of flow diversion procedures being performed, improved healthcare infrastructure, and increased healthcare expenditure.
In 2020, the outbreak of COVID-19 adversely impacted most business activities in North America. However, in 2021, restrictions were eased with the initiation of vaccination drives in various countries in the region to prevent the spread of the disease, which allowed the resumption of business activities. As restrictions eased, more individuals were motivated to schedule health checkups and seek treatment., which increased the diagnostics and treatment plans that were postponed due to COVID-19, which propelled the growth of the flow diversion aneurysm treatment market in North America in 2022 and is expected to do the same during the forecast period.
Buy Now Full Report and Discover More
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Acandis GmbH: The company offers ACCERO Stent and ACCLINO flex plus Stent for the treatment of Flow Diversion Aneurysms.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
The increasing Incidence of intracranial aneurysms is a growing driver in flow diversion aneurysms. A significant driving factor for growth in the flow diversion aneurysm therapy market is an increasing incidence of intracranial aneurysms. The growing prevalence of intracranial aneurysms is driving the demand for effective and advanced treatment options. Flow diversion has emerged as a valuable treatment modality, especially for managing complex and large aneurysms that may be challenging to treat with traditional methods.
However, as the global population continues to age, the incidence of aneurysms is likely to increase, and the demand for flow diversion and other treatment options is increasing. An increase in the number of people vulnerable to aneurysms is anticipated to drive the demand for flow diversion aneurysm treatment market during the forecast period.
The expanding indications of flow diversion procedures are a key trend in the flow diversion aneurysm treatment market. The use of flow diversion aneurysm treatment methods has significantly impacted the aneurysm treatment market due to expanded indications. As the medical community continues to study and confirm the effectiveness of flow diversion in treating various intracranial aneurysms, the demand for flow diverters and associated medical services has risen.
With the broadening of indications, more patients with diverse types of intracranial aneurysms are becoming eligible candidates for flow diversion treatment. Due to increasing evidence, healthcare providers are more likely to offer flow diversion as a treatment option for various types of aneurysms. Due to expanded indications, the demand for flow diversion procedures has increased, which, in turn, is driving the growth of the market in focus during the forecast period.
The higher cost of flow diverter devices is a major challenge faced by the flow diversion aneurysm treatment market. The cost of treating an aneurysm with flow diversion varies widely depending on factors such as location, aneurysm complexity, flow diverter type, medical facility, and additional medical services needed.
Flow diverters are specialized medical devices made of advanced materials, and they can be relatively expensive. The duration of hospital stay after the flow diversion procedure depends on the patient's condition and hospital policies, with longer stays resulting in higher costs. The high costs associated with flow diverter devices will hamper the growth of the market in focus during the forecast period.
Buy Now Full Report and Discover More
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Flow Diversion Aneurysm Treatment Market Customer Landscape
The flow diversion aneurysm treatment market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
Flow Diversion Aneurysm Treatment Market Scope |
|
Report Coverage |
Details |
Page number |
158 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 8.8% |
Market growth 2023-2027 |
USD 2,107.08 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
7.92 |
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
Performing market contribution |
North America at 38% |
Key countries |
US, Canada, UK, Germany, and China |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Acandis GmbH, BALT Group, Cardinal Health Inc., Endologix LLC, Evasc Medical Systems Corp., Imperative Care Inc., InspireMD Inc., Johnson and Johnson, Lepu Medical Technology Beijing Co. Ltd., Medtronic Plc, Merlin MD Pte. Ltd., MicroPort Scientific Corp., Oxford Endovascular Ltd., Penumbra Inc., Rapid Medical Ltd., Siemens AG, Stryker Corp., Terumo Corp., Wallby Medical LLC, and InNeuroCo |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
View Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.